...: The study aimed to assess the safety, immunogenicity, and efficacy of long-term therapy with biosimilar of eculizumab (Elizaria ® ) in paroxysmal nocturnal hemoglobinuria (PNH) patients. Methods: The study included 30 patients with PNH who had completed previous clinical trials. Of these, 25 patients...

... galactomannan (GM) test in serum or bronchoalveolar fluid, which is performed in case of clinical suspicion or as routine screening in patients at high risk who are not receiving anti-mold prophylaxis, for early detection of IA. The aim of this study was to assess in a real-world setting the efficacy...

... (conventional ERd). Alternatively, elotuzumab may often be used every 4 weeks (monthly ERd) in real-world practice. The purpose of this multicenter observational study was to investigate the efficacy and tolerability of monthly ERd. Methods: We investigated the efficacy and tolerability between conventional...

...Li Wang; Jun Xu; Xiaolong Tian; Tingting Lv; Guolin Yuan Background/Aims: The aim of this work was to investigate the efficacy and predictive factors of CLAG treatment in refractory or relapsed (R/R) acute myeloid leukemia (AML) patients. Methods: Sixty-seven R/R AML patients were enrolled...

..., respectively. Multivariate analysis identified bone marrow blast cells ≥10% and a Charlson comorbidity index ≥1 as 2 independent factors for efficacy. In conclusion, very-low-dose decitabine showed relatively good efficacy, good tolerance, and low medical cost in the treatment of intermediate- or high-risk MDS...

..., the efficacy and safety of rituximab treatment in the management of patients with resistant pITP. 27 03 2013 12 09 2013 19 12 2013 © 2013 S. Karger AG, Basel 2013 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...

... of these measures as markers of imatinib efficacy and understand their clinical relationships. Methods: Eighty-four CML patients receiving imatinib treatment were included in this study. Imatinib trough concentration was determined by high-performance liquid chromatography-tandem mass spectrometry. Real-time...

.... Efficacy Leukaemia Mitozantrone Toxicity Hemato-Oncology and Hemato-Immunology. Proc. 2nd Int. Conf., Catania 1986 Acta haemat. 78: suppl. 1. pp. 136-138 (1987) e 1987 S. Karger AG, Basel 0001-5792/87/0787-0136 $ 2.75/0 The Role of Mitozantrone in the Treatment of Acute Leukaemia H. Grant Prentice...